Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seroquel XR for MDD in Peri and Postmenopausal Women
NCT00723970Phase 4Completed
- Sponsor
- McMaster University
- Start
- Jun 2007
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of quetiapine in major depressive disorder (MDD), Insomnia and hot flashes, sponsored by McMaster University. Primary endpoint: Montgomery-Åsberg Depression Rating Scale at 8 weeks. Started Jun 2007; status: completed.
02
Drugs
quetiapine
03
Conditions
major depressive disorder (MDD)Insomniahot flashes
Beyond the preview
Go deeper on NCT00723970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00723970.